[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Registration::
Contact us::
Site Facilities::
Webmail::
::
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
:: Volume 35, Issue 1 (spring 2025) ::
MEDICAL SCIENCES 2025, 35(1): 1-13 Back to browse issues page
A review of the use of cyanobacterial metabolites in the treatment of viral and cancer diseases
Bahareh Nowruzi1 , Fatemeh Bagheri2
1- Associate Professor, Department of Biotechnology, Faculty of Converging Sciences and Technologies, Islamic Azad University, Science and Research Branch, Tehran, Iran , bahare77biol@gmail.com
2- Faculty of Pharmacy and Pharmaceutical Sciences, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
Abstract:   (150 Views)

Many medical and non-medical research laboratories around the world are constantly trying to produce an effective vaccine or antiviral medicine. Current medical knowledge of the world has made significant progress in line with the corona virus and cancer treatment. Meanwhile, many natural compounds found in cyanobacteria have attracted the attention of many physicians due to their durability and high reliability. Cyanobacteria are rich in bioactive compounds that exhibit diverse biological activities including anti-proliferative, cytotoxic and anti-neoplastic properties. Many of these compounds are currently being studied in clinical trials. In this review article, newly discovered bioactive compounds from different cyanobacteria species that have strong antiviral activity against respiratory infections and also compounds such as apratoxin, simplostatin 1, bartolosides, chylobolid, bisbromoamides, carmaphysins and anamides that have anticancer activity on numerous cancer cell lines are introduced. The studies show that currently, there are no clear guidelines on the approval of bioactive compounds derived from cyanobacteria for the treatment of diseases. Although the use of these compounds is not usually accompanied by side effects, more research should be focused on these compounds to increase their safety and effectiveness. In this review article, by studying the latest available articles, the effectiveness of natural compounds in cyanobacteria in the treatment of viral and cancer diseases is discussed.

Keywords: Antiviral drugs, Corona virus, Cyanobacteria, Anticancer compounds
Full-Text [PDF 967 kb]   (47 Downloads)    
Semi-pilot: Review | Subject: Biology
Received: 2024/06/23 | Accepted: 2024/08/14 | Published: 2025/03/30
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Nowruzi B, Bagheri F. A review of the use of cyanobacterial metabolites in the treatment of viral and cancer diseases. MEDICAL SCIENCES 2025; 35 (1) :1-13
URL: http://tmuj.iautmu.ac.ir/article-1-2273-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 35, Issue 1 (spring 2025) Back to browse issues page
فصلنامه علوم پزشکی دانشگاه آزاد اسلامی واحد پزشکی تهران Medical Science Journal of Islamic Azad Univesity - Tehran Medical Branch
Persian site map - English site map - Created in 0.08 seconds with 37 queries by YEKTAWEB 4691